Related references
Note: Only part of the references are listed.Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
Timothy N. Kwan et al.
PROSTATE INTERNATIONAL (2021)
68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
Giuseppe Carlucci et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer
Andrea Farolfi et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2020)
Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer
Burcak Yilmaz et al.
PROSTATE (2019)
Diagnostic accuracy of 68Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68Ga-PSMA PET to mpMRI
Matthijs J. Scheltema et al.
BJU INTERNATIONAL (2019)
Multimodality Imaging of Prostate Cancer
Soleen Ghafoor et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
The effect of 5 alpha-reductase inhibitor therapy on prostate cancer detection in the era of multi-parametric magnetic resonance imaging
Jung Kwon Kim et al.
SCIENTIFIC REPORTS (2019)
Characteristics of missed prostate cancer lesions on 3T multiparametric-MRI in 518 patients: based on PI-RADSv2 and using whole-mount histopathology reference
Amirhossein Mohammadian Bajgiran et al.
ABDOMINAL RADIOLOGY (2019)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
V Kasivisvanathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate
Samuel Borofsky et al.
RADIOLOGY (2018)
Diagnostic Accuracy of Ga-68-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer
Robert M. Hicks et al.
RADIOLOGY (2018)
Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer
Pim J. van Leeuwen et al.
BJU INTERNATIONAL (2017)
Diagnostic Value of Integrated PET/MRI for Detection and Localization of Prostate Cancer: Comparative Study of Multiparametric MRI and PET/CT
Myoung Seok Lee et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies
Giampiero Giovacchini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Intraindividual Comparison of 18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study
Claudia Kesch et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
68Ga-PSMA-11 PET/CT in Newly Diagnosed Carcinoma of the Prostate: Correlation of Intraprostatic PSMA Uptake with Several Clinical Parameters
Stefan A. Koerber et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed et al.
LANCET (2017)
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2
Jeffrey C. Weinreb et al.
EUROPEAN UROLOGY (2016)
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Jurgen J. Futterer et al.
EUROPEAN UROLOGY (2015)
Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients
Marino Cimitan et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients
Mads H. Poulsen et al.
BJU INTERNATIONAL (2012)
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
S. Schwarzenboeck et al.
THERANOSTICS (2012)
Is there a role for C-11-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase < 1.5 ng/ml?
Paolo Castellucci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In-Capromab Pendetide SPECT/CT
David M. Schuster et al.
RADIOLOGY (2011)
Role of 18F-choline PET/CT in evaluation of patients with prostate carcinoma
Marina Hodolic
RADIOLOGY AND ONCOLOGY (2011)
[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study
Mads H. Poulsen et al.
BJU INTERNATIONAL (2010)
[F-18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology based study
T. Steuber et al.
EUROPEAN JOURNAL OF CANCER (2010)
11C-Choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer:: Comparison with clinical staging nomograms
Riccardo Schiavina et al.
EUROPEAN UROLOGY (2008)
Share Paper
